Fingolimod CFTY720D2399
Full Title
A single arm, open-label, multicenter study evaluating the lng-term safety and tolerability of 0.5mg fingolimod (FTY720) administered orally once daily in patients with relapsing forms of multiple sclerosis.
A single arm, open-label, multicenter study evaluating the lng-term safety and tolerability of 0.5mg fingolimod (FTY720) administered orally once daily in patients with relapsing forms of multiple sclerosis.